Literature DB >> 21714113

Expression of mortalin detected in human liver cancer by tissue microarrays.

Xi Chen1, Bo Xu, Hongyan Li, Ling Yang, Ji Zuo, Wen Liu, Chenghai Liu.   

Abstract

Mortalin is a highly conserved molecular chaperone in the heat shock protein (HSP) 70 family, which plays a role in carcinogenesis. The relationship between tumors and the expression of mortalin is not fully elucidated. In this study, human tumor specimens from various organs of liver cancer at different stages and cultured liver cancer cells were used to study the expression pattern of mortalin. Through immunohistochemistry we showed that mortalin was significantly higher in tumors than in adjacent benign tissues. Using liver tissue microarrays tested on hepatocellular carcinomas, mortalin expression was consecutively higher with advanced tumor stages. Mortalin expression on the cultured liver cancer cells were characterized with immunocytochemistry, Real-time PCR, and western blot. The results showed that the expression level is markedly higher in the SMMC 7721 (a liver-derived tumor cell line) than in the HL 7702 (a normal liver cell line) in the protein level only. Understanding the role of mortalin in tumors may lead to development of a new therapeutic target in cancer treatment.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714113     DOI: 10.1002/ar.21433

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  6 in total

1.  Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells.

Authors:  Nupur Nigam; Abhinav Grover; Sukriti Goyal; Shashank P Katiyar; Priyanshu Bhargava; Pi-Chao Wang; Durai Sundar; Sunil C Kaul; Renu Wadhwa
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

2.  Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase.

Authors:  Panadda Rojpibulstit; Suthathip Kittisenachai; Songchan Puthong; Sirikul Manochantr; Pornpen Gamnarai; Sarawut Jitrapakdee; Sittiruk Roytrakul
Journal:  Cancer Cell Int       Date:  2014-07-22       Impact factor: 5.722

3.  NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin.

Authors:  Shan Li; Mengyuan Lv; Shi Qiu; Jiaqi Meng; Wen Liu; Ji Zuo; Ling Yang
Journal:  J Cell Mol Med       Date:  2019-04-14       Impact factor: 5.310

4.  Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of p53 in cancer cells harbouring wild type and p53Ser46 mutant.

Authors:  Seyad Shefrin; Anissa Nofita Sari; Vipul Kumar; Huayue Zhang; Hazna Noor Meidinna; Sunil C Kaul; Renu Wadhwa; Durai Sundar
Journal:  Curr Res Struct Biol       Date:  2022-09-13

5.  Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer.

Authors:  Vishal Chandra; Rajani Rai; Doris Mangiaracina Benbrook
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

6.  The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.

Authors:  Haidan Jin; Meiying Ji; Liyan Chen; Qixiang Liu; Shuanlong Che; Ming Xu; Zhenhua Lin
Journal:  J Exp Clin Cancer Res       Date:  2016-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.